Novavax, Inc. (NASDAQ:NVAX) to Post Q1 2024 Earnings of ($0.85) Per Share, HC Wainwright Forecasts

Novavax, Inc. (NASDAQ:NVAX – Free Report) – Investment analysts at HC Wainwright issued their Q1 2024 earnings estimates for shares of Novavax in a report released on Friday, March 1st. HC Wainwright analyst V. Bernardino expects that the biopharmaceutical company will post earnings of ($0.85) per share for the quarter. HC Wainwright has a “Buy” […]

Leave a Reply

Your email address will not be published.

Previous post Lyft, Inc. (NASDAQ:LYFT) Given Consensus Rating of “Hold” by Analysts
Next post Q1 2024 Earnings Forecast for NewAmsterdam Pharma (NASDAQ:NAMS) Issued By Leerink Partnrs